Leu20-Gly718 with Human IgG1 Fc at C-Terminus
110-130kDa (Reducing)
PBS, PH7.4
Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation.
· 12 months from date of receipt, lyophilized powder stored at -20 to -80℃.
· 3 months, -20 to -80℃ under sterile conditions after reconstitution.
· 1 week, 2 to 8℃ under sterile conditions after reconstitution.
· Please avoid repeated freeze-thaw cycles.
1、Guven A. et al. (2021) Development and validation of an immunoassay for quantification of NCAM-1 in human plasma. Journal of Pharmaceutical and Biomedical Analysis. 197: 113981.
Neural Cell Adhesion Molecule 1 (NCAM-1), a multifunctional member of the immunoglobulin superfamily, is expressed on the surfaces of neurons, glial cells, skeletal muscle, and natural killer cells. NCAM-1 plays a role in cell-cell adhesion and is crucial for the development of the nervous system. It is also involved in the expansion of T cells and dendritic cells, which are key players in immune surveillance.
1μg (R: reducing condition).
Immobilized NCAM-1/CD56 Fc Chimera Protein, Human (Cat. No. UA010813) at 2.0μg/mL (100μL/well) can bind Biotinylated Lorvotuzumab with EC50 of 8.22-12.4 ng/mL.
Immobilized NCAM-1/CD56 Fc Chimera Protein, Human (Cat. No. UA010813) at 1.0μg/mL (100μL/well) can bind NCAM-1/CD56 Mouse mAb (S-577-58) (Cat. No. S0B0382) with EC50 of 2.37-3.64 ng/mL.